Matthias Gutekunst - Concepedia

Author

Matthias Gutekunst

Robert Bosch Hospital

Also Known As

Gutekunst, Matthias, M Gutekunst, Matthias Gutekunst

Publications

826

Citations

H-Index

Concepts

All Affiliations

Robert Bosch Hospital Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology Weizmann Institute of Science University of Tübingen

About

Matthias Gutekunst is an author at Robert Bosch Hospital specializing in cell death, cell biology, and medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	181
2	Cell Biology	3	3	181
3	Immunology	2	2	121
4	Pharmacology	1	1	60
5	Cell Signaling	1	1	60

Matthias Gutekunst

Publications

442

Citations

H-Index

Page 1

	Year	Citations
Capturing complex tumour biology in vitro: histological and molecular characterisation of precision cut slices Emma Jane Davies, Meng Dong, Matthias Gutekunst, Scientific Reports	2015	115
p53 Hypersensitivity Is the Predominant Mechanism of the Unique Responsiveness of Testicular Germ Cell Tumor (TGCT) Cells to Cisplatin Matthias Gutekunst, Moshe Oren, Andrea Weilbacher, PLoS ONE Unique ResponsivenessP53 FunctionGerm CellOncogenic AgentMedicine	2011	96
RITA can induce cell death in p53-defective cells independently of p53 function via activation of JNK/SAPK and p38 Andrea Weilbacher, Matthias Gutekunst, Moshe Oren, Cell Death and Disease Cancer ResearchP53 FunctionP53-defective CellsOncologyWtp53 Cells	2014	60
Cisplatin Hypersensitivity of Testicular Germ Cell Tumors Is Determined by High Constitutive Noxa Levels Mediated by Oct-4 Matthias Gutekunst, Thomas Mueller, Andrea Weilbacher, Cancer Research	2013	60
Discrepant NOXA (PMAIP1) transcript and NOXA protein levels: a potential Achilles’ heel in mantle cell lymphoma Michael A. Dengler, Andrea Weilbacher, Matthias Gutekunst, Cell Death and Disease	2014	58
Oncogenic Stress Induced by Acute Hyper-Activation of Bcr-Abl Leads to Cell Death upon Induction of Excessive Aerobic Glycolysis Michael A. Dengler, Annette M. Staiger, Matthias Gutekunst, PLoS ONE	2011	28
Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity Ioanna Skorta, Moshe Oren, Christiane Markwardt, Cancer Research Cisplatin SensitivityMixed-phenotype Acute LeukemiaImmunologyCell DeathTumor Biology	2009	25

Page 1